XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
REVERSE MERGER (Tables)
6 Months Ended
Jun. 30, 2018
REVERSE MERGER [Abstract]  
Business Acquisition, Pro Forma Information

The following unaudited pro forma information presents the Company's financial results as if the acquisition of Transgenomic had occurred on January 1, 2017 and combines Transgenomic’s unaudited condensed consolidated statement of operations for the three and six months ended June 30, 2017 with Precipio’s unaudited condensed statement of operations for the three and six months ended June 30, 2017:







 

 

 

 

 

 

Dollars in thousands, except per share amounts

 

June 30, 2017



 

 

Three Months Ended

 

 

Six Months Ended

Net sales

 

$

565 

 

$

1,472 

Net loss available to common stockholders

 

 

(11,086)

 

 

(13,864)

Loss per common share

 

$

(1.73)

 

$

(2.16)